<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36840837</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1749-0774</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Human cell</Title><ISOAbbreviation>Hum Cell</ISOAbbreviation></Journal><ArticleTitle>The role of non-coding RNA in lupus nephritis.</ArticleTitle><Pagination><StartPage>923</StartPage><EndPage>936</EndPage><MedlinePgn>923-936</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13577-023-00883-w</ELocationID><Abstract><AbstractText>Systemic lupus erythematosus (SLE) is a common autoimmune disease with multiple manifestations. The renal implication, also called lupus nephritis (LN) is the most regular type of complication and results in adverse outcomes. Multiple studies revealed the importance of non-coding RNA in diseases, likewise observed in nephropathies, particularly LN. Long-non-coding RNA (lncRNA) is a group of RNA that are more than 200 nucleotides in length. And in circular RNA (circRNA), the head and tail of RNA are connected by a 3'&#x2009;&#x2192;&#x2009;5' phosphodiester bond. Both two types of non-coding RNA play important roles in LN pathogenesis through the competitive endogenous RNA (ceRNA) effect. LncRNAs and circRNAs can sponge miRNAs and consequently act on downstream signaling pathways, which are capable to influence various aspects of LN, including cell proliferation, inflammation, and oxidative stress. And lncRNAs and circRNAs have the potential to act as biomarkers to diagnose LN and distinguish whether SLE patients with LN or not. In the future, lncRNAs and circRNAs may be accessible therapeutic targets.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s) under exclusive licence to Japan Human Cell Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Hanzhi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Nephrology, The First Affiliated Hospital, Sun Yat-Sen University, 58 Zhongshan Second Road, Yuexiu District, Guangdong Province, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NHC Key Laboratory of Clinical Nephrology (Sun Yat-Sen University) and Guangdong Provincial Key Laboratory of Nephrology, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Qinghua</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0002-6385-5482</Identifier><AffiliationInfo><Affiliation>Department of Nephrology, The First Affiliated Hospital, Sun Yat-Sen University, 58 Zhongshan Second Road, Yuexiu District, Guangdong Province, China. liuqhua6@mail.sysu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NHC Key Laboratory of Clinical Nephrology (Sun Yat-Sen University) and Guangdong Provincial Key Laboratory of Nephrology, Guangzhou, 510080, China. liuqhua6@mail.sysu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>81370863</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Hum Cell</MedlineTA><NlmUniqueID>8912329</NlmUniqueID><ISSNLinking>0914-7470</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000079962">RNA, Circular</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D062085">RNA, Long Noncoding</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000079962" MajorTopicYN="N">RNA, Circular</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062085" MajorTopicYN="Y">RNA, Long Noncoding</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biomarker</Keyword><Keyword MajorTopicYN="N">Circular RNA</Keyword><Keyword MajorTopicYN="N">Long-non-coding RNA</Keyword><Keyword MajorTopicYN="N">Lupus nephritis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>11</Hour><Minute>25</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36840837</ArticleId><ArticleId IdType="doi">10.1007/s13577-023-00883-w</ArticleId><ArticleId IdType="pii">10.1007/s13577-023-00883-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Anders HJ, Saxena R, Zhao MH, Parodis I, Salmon JE, Mohan C. Lupus nephritis. Nat Rev Dis Primers. 2020;6:7.</Citation><ArticleIdList><ArticleId IdType="pubmed">31974366</ArticleId><ArticleId IdType="doi">10.1038/s41572-019-0141-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanly JG, O&#x2019;Keeffe AG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, et al. The frequency and outcome of lupus nephritis: results from an international inception cohort study. Rheumatol (Oxford). 2016;55:252&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kev311</ArticleId></ArticleIdList></Reference><Reference><Citation>Croca SC, Rodrigues T, Isenberg DA. Assessment of a lupus nephritis cohort over a 30-year period. Rheumatol (Oxford). 2011;50:1424&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/ker101</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyn-Cook BD, Xie C, Oates J, Treadwell E, Word B, Hammons G, et al. Increased expression of toll-like receptors (TLRs) 7 and 9 and other cytokines in systemic lupus erythematosus (SLE) patients: ethnic differences and potential new targets for therapeutic drugs. Mol Immunol. 2014;61:38&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">24865418</ArticleId><ArticleId IdType="doi">10.1016/j.molimm.2014.05.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsokos GC, Lo MS, Costa Reis P, Sullivan KE. New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol. 2016;12:716&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">27872476</ArticleId><ArticleId IdType="doi">10.1038/nrrheum.2016.186</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma S, Fitzgerald KA, Cancro MP, Marshak-Rothstein A. Nucleic acid-sensing receptors: rheostats of autoimmunity and autoinflammation. J Immunol. 2015;195:3507&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">26432899</ArticleId><ArticleId IdType="doi">10.4049/jimmunol.1500964</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortensen ES, Rekvig OP. Nephritogenic potential of anti-DNA antibodies against necrotic nucleosomes. J Am Soc Nephrol. 2009;20:696&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pubmed">19329762</ArticleId><ArticleId IdType="doi">10.1681/ASN.2008010112</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosch X. Systemic lupus erythematosus and the neutrophil. N Engl J Med. 2011;365:758&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">21864171</ArticleId><ArticleId IdType="doi">10.1056/NEJMcibr1107085</ArticleId></ArticleIdList></Reference><Reference><Citation>Hakkim A, F&#xfc;rnrohr BG, Amann K, Laube B, Abed UA, Brinkmann V, et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci U S A. 2010;107:9813&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">20439745</ArticleId><ArticleId IdType="pmc">2906830</ArticleId><ArticleId IdType="doi">10.1073/pnas.0909927107</ArticleId></ArticleIdList></Reference><Reference><Citation>Lema GP, Maier H, Nieto E, Vielhauer V, Luckow B, Mampaso F, et al. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J Am Soc Nephrol. 2001;12:1369&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">11423566</ArticleId><ArticleId IdType="doi">10.1681/ASN.V1271369</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinloch AJ, Chang A, Ko K, Henry Dunand CJ, Henderson S, Maienschein-Cline M, et al. Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis. Arthritis Rheumatol. 2014;66:3359&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">25306868</ArticleId><ArticleId IdType="pmc">4264660</ArticleId><ArticleId IdType="doi">10.1002/art.38888</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt T, Paust HJ, Krebs CF, Turner JE, Kaffke A, Bennstein SB, et al. Function of the Th17/interleukin-17A immune response in murine lupus nephritis. Arthritis Rheumatol. 2015;67:475&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">25385550</ArticleId><ArticleId IdType="doi">10.1002/art.38955</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers NM, Ferenbach DA, Isenberg JS, Thomson AW, Hughes J. Dendritic cells and macrophages in the kidney: a spectrum of good and evil. Nat Rev Nephrol. 2014;10:625&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">25266210</ArticleId><ArticleId IdType="pmc">4922410</ArticleId><ArticleId IdType="doi">10.1038/nrneph.2014.170</ArticleId></ArticleIdList></Reference><Reference><Citation>Rother N, van der Vlag J. Disturbed T cell signaling and altered Th17 and regulatory T cell subsets in the pathogenesis of systemic lupus erythematosus. Front Immunol. 2015;6:610.</Citation><ArticleIdList><ArticleId IdType="pubmed">26648939</ArticleId><ArticleId IdType="pmc">4663269</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2015.00610</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong W, Zhu P, Wang Y, Wang Z. Follicular helper T cells in systemic lupus erythematosus: a potential therapeutic target. Autoimmun Rev. 2011;10:299&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pubmed">21111068</ArticleId><ArticleId IdType="doi">10.1016/j.autrev.2010.11.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Birmingham DJ, Hebert LA. The complement system in lupus nephritis. Semin Nephrol. 2015;35:444&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">26573547</ArticleId><ArticleId IdType="doi">10.1016/j.semnephrol.2015.08.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiepe F, Radbruch A. Plasma cells as an innovative target in autoimmune disease with renal manifestations. Nat Rev Nephrol. 2016;12:232&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">26923204</ArticleId><ArticleId IdType="doi">10.1038/nrneph.2016.20</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X, Chen W, Ren G, Zhao L, Guo J, Gong D, et al. Autologous hematopoietic stem cell transplantation for refractory lupus nephritis. Clin J Am Soc Nephrol. 2019;14:719&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">30979713</ArticleId><ArticleId IdType="pmc">6500938</ArticleId><ArticleId IdType="doi">10.2215/CJN.10570918</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsui M, Corey DR. Non-coding RNAs as drug targets. Nat Rev Drug Discov. 2017;16:167&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">27444227</ArticleId><ArticleId IdType="doi">10.1038/nrd.2016.117</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10:155&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">19188922</ArticleId><ArticleId IdType="doi">10.1038/nrg2521</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulitsky I, Bartel DP. lincRNAs: genomics, evolution, and mechanisms. Cell. 2013;154:26&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">23827673</ArticleId><ArticleId IdType="pmc">3924787</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2013.06.020</ArticleId></ArticleIdList></Reference><Reference><Citation>Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12:861&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">22094949</ArticleId><ArticleId IdType="doi">10.1038/nrg3074</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet. 2016;17:272&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">27040487</ArticleId><ArticleId IdType="doi">10.1038/nrg.2016.20</ArticleId></ArticleIdList></Reference><Reference><Citation>So BYF, Yap DYH, Chan TM. MicroRNAs in lupus nephritis-role in disease pathogenesis and clinical applications. Int J Mol Sci. 2021;22:10737.</Citation><ArticleIdList><ArticleId IdType="pubmed">34639078</ArticleId><ArticleId IdType="pmc">8509214</ArticleId><ArticleId IdType="doi">10.3390/ijms221910737</ArticleId></ArticleIdList></Reference><Reference><Citation>Kung JT, Colognori D, Lee JT. Long noncoding RNAs: past, present, and future. Genetics. 2013;193:651&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">23463798</ArticleId><ArticleId IdType="pmc">3583990</ArticleId><ArticleId IdType="doi">10.1534/genetics.112.146704</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayama T, Marr AK, Kino T. Differential expression of glucocorticoid receptor noncoding RNA repressor Gas5 in autoimmune and inflammatory diseases. Horm Metab Res. 2016;48:550&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">27214311</ArticleId><ArticleId IdType="doi">10.1055/s-0042-106898</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, Wu L, Qian J, Qu B, Xia S, La T, et al. Identification of the long noncoding RNA NEAT1 as a novel inflammatory regulator acting through MAPK pathway in human lupus. J Autoimmun. 2016;75:96&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">27481557</ArticleId><ArticleId IdType="doi">10.1016/j.jaut.2016.07.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Zhang F, Ma J, Zhang X, Wu L, Qu B, et al. Association of large intergenic noncoding RNA expression with disease activity and organ damage in systemic lupus erythematosus. Arthritis Res Ther. 2015;17:131.</Citation><ArticleIdList><ArticleId IdType="pubmed">25994030</ArticleId><ArticleId IdType="pmc">4440330</ArticleId><ArticleId IdType="doi">10.1186/s13075-015-0632-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L-H, Xiao B, Zhong M, Li Q, Chen J-Y, Huang J-R, et al. LncRNA NEAT1 accelerates renal mesangial cell injury via modulating the miR-146b/TRAF6/NF-kappa B axis in lupus nephritis. Cell Tissue Res. 2020;382:627&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">32710276</ArticleId><ArticleId IdType="doi">10.1007/s00441-020-03248-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Mello SS, Sinow C, Raj N, Mazur PK, Bieging-Rolett K, Broz DK, et al. Neat1 is a p53-inducible lincRNA essential for transformation suppression. Genes Dev. 2017;31:1095&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pubmed">28698299</ArticleId><ArticleId IdType="pmc">5538433</ArticleId><ArticleId IdType="doi">10.1101/gad.284661.116</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler AA, Johnston DR, Kaur S, Lubin FD. Long noncoding RNA NEAT1 mediates neuronal histone methylation and age-related memory impairment. Sci Signal. 2019. https://doi.org/10.1126/scisignal.aaw9277 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.aaw9277</ArticleId><ArticleId IdType="pubmed">31266852</ArticleId><ArticleId IdType="pmc">7219525</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Deng W, Zhang W. Long non-coding RNA TUG1 protects renal tubular epithelial cells against injury induced by lipopolysaccharide via regulating microRNA-223. Biomed Pharmacother. 2018;104:509&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">29800915</ArticleId><ArticleId IdType="doi">10.1016/j.biopha.2018.05.069</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao XB, Ren GS. LncRNA taurine-upregulated gene 1 promotes cell proliferation by inhibiting MicroRNA-9 in MCF-7 Cells. J Breast Cancer. 2016;19:349&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">28053623</ArticleId><ArticleId IdType="pmc">5204041</ArticleId><ArticleId IdType="doi">10.4048/jbc.2016.19.4.349</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Sun X, Mao C, Guo G, Ye S, Xu J, et al. Upregulation of long noncoding RNA TUG1 promotes cervical cancer cell proliferation and migration. Cancer Med. 2017;6:471&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">28088836</ArticleId><ArticleId IdType="pmc">5313648</ArticleId><ArticleId IdType="doi">10.1002/cam4.994</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang S, Zhang S, Wang P, Yang C, Shang C, Yang J, et al. LncRNA, TUG1 regulates the oral squamous cell carcinoma progression possibly via interacting with Wnt/&#x3b2;-catenin signaling. Gene. 2017;608:49&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">28119088</ArticleId><ArticleId IdType="doi">10.1016/j.gene.2017.01.024</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao H-Y, Li D, Wang Y-P, Lu H-X, Sun J, Li H-B. Clinical significance of reduced expression of lncRNA TUG1 in the peripheral blood of systemic lupus erythematosus patients. Int J Rheum Dis. 2020;23:428&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">31944629</ArticleId><ArticleId IdType="doi">10.1111/1756-185X.13786</ArticleId></ArticleIdList></Reference><Reference><Citation>Crow MK, Olferiev M, Kirou KA. Type I interferons in autoimmune disease. Annu Rev Pathol. 2019;14:369&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">30332560</ArticleId><ArticleId IdType="doi">10.1146/annurev-pathol-020117-043952</ArticleId></ArticleIdList></Reference><Reference><Citation>Banchereau J, Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity. 2006;25:383&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">16979570</ArticleId><ArticleId IdType="doi">10.1016/j.immuni.2006.08.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Z, Ye Z, Xue Z, Wu L, Ouyang Y, Yao C, et al. Identification of renal long non-coding RNA RP11&#x2013;2B6.2 as a positive regulator of type I interferon signaling pathway in lupus nephritis. Front Immunol. 2019;10:975.</Citation><ArticleIdList><ArticleId IdType="pubmed">31130957</ArticleId><ArticleId IdType="pmc">6509587</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2019.00975</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X, Du Y, Cai C, Cai B, Zhu M, Xing C, et al. Inflammasome activation negatively regulates MyD88-IRF7 type I IFN signaling and anti-malaria immunity. Nat Commun. 2018;9:4964.</Citation><ArticleIdList><ArticleId IdType="pubmed">30470758</ArticleId><ArticleId IdType="pmc">6251914</ArticleId><ArticleId IdType="doi">10.1038/s41467-018-07384-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Filardo EJ, Quinn JA, Frackelton AR Jr, Bland KI. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol. 2002;16:70&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">11773440</ArticleId><ArticleId IdType="doi">10.1210/mend.16.1.0758</ArticleId></ArticleIdList></Reference><Reference><Citation>Prossnitz ER, Sklar LA, Oprea TI, Arterburn JB. GPR30: a novel therapeutic target in estrogen-related disease. Trends Pharmacol Sci. 2008;29:116&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">18262661</ArticleId><ArticleId IdType="doi">10.1016/j.tips.2008.01.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi A, Han J, Jia F, Liu C. miR-3175 and miR-134 affect proliferation, invasion and apoptosis of glioma cells through PI3K/AKT signaling pathway. J buon. 2019;24:2465&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">31983121</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni QF, Zhang Y, Yu JW, Hua RH, Wang QH, Zhu JW. miR-92b promotes gastric cancer growth by activating the DAB2IP-mediated PI3K/AKT signalling pathway. Cell Prolif. 2020;53: e12630.</Citation><ArticleIdList><ArticleId IdType="pubmed">31713929</ArticleId><ArticleId IdType="doi">10.1111/cpr.12630</ArticleId></ArticleIdList></Reference><Reference><Citation>He J, Ma J, Ren B, Liu A. Advances in systemic lupus erythematosus pathogenesis via mTOR signaling pathway. Semin Arthritis Rheum. 2020;50:314&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">31796213</ArticleId><ArticleId IdType="doi">10.1016/j.semarthrit.2019.09.022</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge F, Wang F, Yan X, Li Z, Wang X. Association of BAFF with PI3K/Akt/mTOR signaling in lupus nephritis. Mol Med Rep. 2017;16:5793&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">28849060</ArticleId><ArticleId IdType="pmc">5865758</ArticleId><ArticleId IdType="doi">10.3892/mmr.2017.7367</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai B, Cai J, Yin Z, Jiang X, Yao C, Ma J, et al. Long non-coding RNA expression profiles in neutrophils revealed potential biomarker for prediction of renal involvement in SLE patients. Rheumatology. 2021;60:1734&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">33068407</ArticleId><ArticleId IdType="doi">10.1093/rheumatology/keaa575</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YC, Kuo PY, Chou YC, Chong HE, Hsieh YT, Yang ML, et al. Up-regulated expression of pro-apoptotic long noncoding RNA lincRNA-p21 with enhanced cell apoptosis in lupus nephritis. Int J Mol Sci. 2020;22:301.</Citation><ArticleIdList><ArticleId IdType="pubmed">33396699</ArticleId><ArticleId IdType="pmc">7795010</ArticleId><ArticleId IdType="doi">10.3390/ijms22010301</ArticleId></ArticleIdList></Reference><Reference><Citation>Amirinejad R, Rezaei M, Shirvani-Farsani Z. An update on long intergenic noncoding RNA p21: a regulatory molecule with various significant functions in cancer. Cell Biosci. 2020;10:82.</Citation><ArticleIdList><ArticleId IdType="pubmed">32582435</ArticleId><ArticleId IdType="pmc">7310005</ArticleId><ArticleId IdType="doi">10.1186/s13578-020-00445-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D, et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell. 2010;142:409&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">20673990</ArticleId><ArticleId IdType="pmc">2956184</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2010.06.040</ArticleId></ArticleIdList></Reference><Reference><Citation>Heward JA, Lindsay MA. Long non-coding RNAs in the regulation of the immune response. Trends Immunol. 2014;35:408&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">25113636</ArticleId><ArticleId IdType="pmc">7106471</ArticleId><ArticleId IdType="doi">10.1016/j.it.2014.07.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Guermonprez P, Helft J, Claser C, Deroubaix S, Karanje H, Gazumyan A, et al. Inflammatory Flt3l is essential to mobilize dendritic cells and for T cell responses during plasmodium infection. Nat Med. 2013;19:730&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">23685841</ArticleId><ArticleId IdType="pmc">3914008</ArticleId><ArticleId IdType="doi">10.1038/nm.3197</ArticleId></ArticleIdList></Reference><Reference><Citation>Lande R, Ganguly D, Facchinetti V, Frasca L, Conrad C, Gregorio J, et al. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med. 2011;3:73ra19.</Citation><ArticleIdList><ArticleId IdType="pubmed">21389263</ArticleId><ArticleId IdType="pmc">3399524</ArticleId><ArticleId IdType="doi">10.1126/scitranslmed.3001180</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P, Xue Y, Han Y, Lin L, Wu C, Xu S, et al. The STAT3-binding long noncoding RNA lnc-DC controls human dendritic cell differentiation. Science. 2014;344:310&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">24744378</ArticleId><ArticleId IdType="doi">10.1126/science.1251456</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon M, Blair PA, Isenberg DA, Mauri C. A regulatory feedback between plasmacytoid dendritic cells and regulatory B cells is aberrant in systemic lupus erythematosus. Immunity. 2016;44:683&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">26968426</ArticleId><ArticleId IdType="pmc">4803914</ArticleId><ArticleId IdType="doi">10.1016/j.immuni.2016.02.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma CS, Avery DT, Chan A, Batten M, Bustamante J, Boisson-Dupuis S, et al. Functional STAT3 deficiency compromises the generation of human T follicular helper cells. Blood. 2012;119:3997&#x2013;4008.</Citation><ArticleIdList><ArticleId IdType="pubmed">22403255</ArticleId><ArticleId IdType="pmc">3355712</ArticleId><ArticleId IdType="doi">10.1182/blood-2011-11-392985</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen Z, Zhong Z, Darnell JE Jr. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell. 1995;82:241&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">7543024</ArticleId><ArticleId IdType="doi">10.1016/0092-8674(95)90311-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang LF, Tian JH, Zhang XZ, Wang H, Huang CH. Lnc-DC regulates cellular turnover and the HBV-induced immune response by TLR9/STAT3 signaling in dendritic cells. Cell Mol Biol Lett. 2018. https://doi.org/10.1186/s11658-018-0108-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s11658-018-0108-y</ArticleId><ArticleId IdType="pubmed">30202418</ArticleId><ArticleId IdType="pmc">6122708</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu G-C, Li J, Leng R-X, Li X-P, Li X-M, Wang D-G, et al. Identification of long non-coding RNAs GAS5, linc0597 and lnc-DC in plasma as novel biomarkers for systemic lupus erythematosus. Oncotarget. 2017;8:23650&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">28423570</ArticleId><ArticleId IdType="pmc">5410334</ArticleId><ArticleId IdType="doi">10.18632/oncotarget.15569</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo H, Zhang X, Chen Q, Bao Y, Dong C, Wang X. miR-132 suppresses the migration and invasion of lung cancer cells by blocking USP9X-induced epithelial-mesenchymal transition. Am J Transl Res. 2018;10:224&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">29423007</ArticleId><ArticleId IdType="pmc">5801360</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed RF, Shaker OG, Abdelghany HM, Helmy Abdallah N, Elsayed SH, Kamel BA. Role of micro-RNA132 and its long non coding SOX2 in diagnosis of lupus nephritis. Lupus. 2022;31:89&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">35019799</ArticleId><ArticleId IdType="doi">10.1177/09612033211067166</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleh AA, Kasem HE, Zahran E, El-Hefnawy SM. Dysregulation of cell-free long non-coding RNAs (NEAT2, CTC-471J1.2 and lnc-DC) in Egyptian systemic lupus and lupus nephritis patients. Meta Gene. 2020. https://doi.org/10.1016/j.mgene.2020.100665 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mgene.2020.100665</ArticleId></ArticleIdList></Reference><Reference><Citation>Rong C, Xu H, Yan C, Wei F, Zhou H, Guan X. Linc8986 and linc0597 in plasma are novel biomarkers for systemic lupus erythematosus. Exp Ther Med. 2021. https://doi.org/10.3892/etm.2021.10644 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2021.10644</ArticleId><ArticleId IdType="pubmed">34584555</ArticleId><ArticleId IdType="pmc">8422381</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin J, Sun H, Shi C, Yang H, Wu Y, Li W, et al. Circular RNA in renal diseases. J Cell Mol Med. 2020;24:6523&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">32333642</ArticleId><ArticleId IdType="pmc">7299708</ArticleId><ArticleId IdType="doi">10.1111/jcmm.15295</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia X, Tang X, Wang S. Roles of CircRNAs in autoimmune diseases. Front Immunol. 2019;10:639.</Citation><ArticleIdList><ArticleId IdType="pubmed">31001261</ArticleId><ArticleId IdType="pmc">6454857</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2019.00639</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z, Sun B, Huang S, Zhao L. Roles of circular RNAs in immune regulation and autoimmune diseases. Cell Death Dis. 2019;10:503.</Citation><ArticleIdList><ArticleId IdType="pubmed">31243263</ArticleId><ArticleId IdType="pmc">6594938</ArticleId><ArticleId IdType="doi">10.1038/s41419-019-1744-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Li K, Lai W, Li X, Wang H, Yang J, et al. Comprehensive circular RNA profiles in plasma reveals that circular RNAs can be used as novel biomarkers for systemic lupus erythematosus. Clin Chim Acta. 2018;480:17&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">29360436</ArticleId><ArticleId IdType="doi">10.1016/j.cca.2018.01.026</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Zhang C, Wu Z, Chen Y, Shi W. CircIBTK inhibits DNA demethylation and activation of AKT signaling pathway via miR-29b in peripheral blood mononuclear cells in systemic lupus erythematosus. Arthritis Res Ther. 2018;20:118.</Citation><ArticleIdList><ArticleId IdType="pubmed">29884225</ArticleId><ArticleId IdType="pmc">5993996</ArticleId><ArticleId IdType="doi">10.1186/s13075-018-1618-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Su W, Wang Y, Wang F, Zhang B, Zhang H, Shen Y, et al. Circular RNA hsa_circ_0007059 indicates prognosis and influences malignant behavior via AKT/mTOR in oral squamous cell carcinoma. J Cell Physiol. 2019;234:15156&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">30680715</ArticleId><ArticleId IdType="pmc">6617778</ArticleId><ArticleId IdType="doi">10.1002/jcp.28156</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao S, Yu Y, Liu L, Meng J, Li G. Circular RNA hsa_circ_0007059 restrains proliferation and epithelial-mesenchymal transition in lung cancer cells via inhibiting microRNA-378. Life Sci. 2019;233: 116692.</Citation><ArticleIdList><ArticleId IdType="pubmed">31351967</ArticleId><ArticleId IdType="doi">10.1016/j.lfs.2019.116692</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo P-W, Huang H-T, Ma J, Zuo Y, Huang D, He L-L, et al. Circular RNA-0007059 protects cell viability and reduces inflammation in a nephritis cell model by inhibiting microRNA-1278/SHP-1/STAT3 signaling. Mol Med. 2021. https://doi.org/10.1186/s10020-021-00372-6 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-021-00372-6</ArticleId><ArticleId IdType="pubmed">34736391</ArticleId><ArticleId IdType="pmc">8567594</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong ZZ, Maiese K. The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury. Histol Histopathol. 2007;22:1251&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">17647198</ArticleId><ArticleId IdType="pmc">2515712</ArticleId></ArticleIdList></Reference><Reference><Citation>Der E, Suryawanshi H, Morozov P, Kustagi M, Goilav B, Ranabothu S, et al. Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways. Nat Immunol. 2019;20:915&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">31110316</ArticleId><ArticleId IdType="pmc">6584054</ArticleId><ArticleId IdType="doi">10.1038/s41590-019-0386-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman FA, Nyimanu D, Maguire JJ, Davenport AP, Newby DE, Dhaun N. The therapeutic potential of apelin in kidney disease. Nat Rev Nephrol. 2021;17:840&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">34389827</ArticleId><ArticleId IdType="pmc">8361827</ArticleId><ArticleId IdType="doi">10.1038/s41581-021-00461-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z, Wu L, Chen L. Apelin/APJ system: a novel potential therapy target for kidney disease. J Cell Physiol. 2018;233:3892&#x2013;900.</Citation><ArticleIdList><ArticleId IdType="pubmed">28796300</ArticleId><ArticleId IdType="doi">10.1002/jcp.26144</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Gao C, Di X, Cui S, Liang W, Sun W, et al. Hsa_circ_0123190 acts as a competitive endogenous RNA to regulate APLNR expression by sponging hsa-miR-483&#x2013;3p in lupus nephritis. Arthritis Res Ther. 2021. https://doi.org/10.1186/s13075-020-02404-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-020-02404-8</ArticleId><ArticleId IdType="pubmed">34930431</ArticleId><ArticleId IdType="pmc">8686533</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z-Q, Ding Y, Huang X-Y, Xiang W, He X-J. CircELK4 contributes to lupus nephritis by acting as a miR-27b-3p Sponge to Regulate STING/IRF3/IFN-I Signaling. Inflammation. 2021;44:2106&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">34091806</ArticleId><ArticleId IdType="doi">10.1007/s10753-021-01487-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Hao P, Zhang H, Xu C, Zhao J. MicroRNA-223 inhibits lipopolysaccharide-induced inflammatory response by directly targeting Irak1 in the nucleus pulposus cells of intervertebral disc. IUBMB Life. 2018;70:479&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">29707878</ArticleId><ArticleId IdType="doi">10.1002/iub.1747</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu H, Qu X, Wang F, Chang J, Cheng R, Song X, et al. MicroRNA-206 promotes lipopolysaccharide-induced inflammation injury via regulation of IRAK1 in MRC-5 cells. Int Immunopharmacol. 2019;73:590&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">31279225</ArticleId><ArticleId IdType="doi">10.1016/j.intimp.2019.05.029</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z, Tian Z, Zhang M, Zhang Y, Ni B, Hao F. Upregulated IL-1 receptor-associated Kinase 1 (IRAK1) in systemic lupus erythematosus: IRAK1 inhibition represses Th17 differentiation with therapeutic potential. Immunol Invest. 2018;47:468&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">29611775</ArticleId><ArticleId IdType="doi">10.1080/08820139.2018.1458105</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan J, Wang X, Cang X, Jiang Y, Tang R. Hsa_circ_0010957 knockdown attenuates lipopolysaccharide-induced HK2 cell injury by regulating the miR-1224-5p/IRAK1 axis. Central Eur J Immunol. 2021;46:314&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/ceji.2021.108772</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber GN. STING: infection, inflammation and cancer. Nat Rev Immunol. 2015;15:760&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">26603901</ArticleId><ArticleId IdType="pmc">5004891</ArticleId><ArticleId IdType="doi">10.1038/nri3921</ArticleId></ArticleIdList></Reference><Reference><Citation>Luan J, Jiao C, Kong W, Fu J, Qu W, Chen Y, et al. circHLA-C plays an important role in lupus nephritis by sponging miR-150. Mol Ther-Nucleic Acids. 2018;10:245&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">29499937</ArticleId><ArticleId IdType="doi">10.1016/j.omtn.2017.12.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H, Hasni SA, Perez P, Tandon M, Jang S-I, Zheng C, et al. miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1. J Am Soc Nephrol. 2013;24:1073&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">23723424</ArticleId><ArticleId IdType="pmc">3699828</ArticleId><ArticleId IdType="doi">10.1681/ASN.2012080849</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouyang Q, Huang Q, Jiang Z, Zhao J, Shi G-P, Yang M. Using plasma circRNA_002453 as a novel biomarker in the diagnosis of lupus nephritis. Mol Immunol. 2018;101:531&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">30172209</ArticleId><ArticleId IdType="doi">10.1016/j.molimm.2018.07.029</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian S, Liu X, Fan Q, Ma J, Yao L, Li Y. Microarray expression and functional analysis of circular RNAs in the glomeruli of NZB/W F1 mice with lupus nephritis. Exp Ther Med. 2019;18:2813&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">31555374</ArticleId><ArticleId IdType="pmc">6755417</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo G, Wang H, Ye L, Shi X, Yan K, Lin K, et al. Hsa_circ_0000479 as a novel diagnostic biomarker of systemic lupus erythematosus. Front Immunol. 2019;10:2281.</Citation><ArticleIdList><ArticleId IdType="pubmed">31608065</ArticleId><ArticleId IdType="pmc">6771011</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2019.02281</ArticleId></ArticleIdList></Reference><Reference><Citation>Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi pp. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature. 2010;465:1033&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">20577206</ArticleId><ArticleId IdType="pmc">3206313</ArticleId><ArticleId IdType="doi">10.1038/nature09144</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Shi L, Zheng X, Liu X, Qian J. Modulation of miR-548m encoded by X chromosome on the PTEN pathway in systemic lupus erythematosus. Clin Exp Rheumatol. 2022;40:56&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">33635226</ArticleId><ArticleId IdType="doi">10.55563/clinexprheumatol/yjsbqm</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu XN, Ye YX, Niu JW, Li Y, Li X, You X, et al. Defective PTEN regulation contributes to B cell hyperresponsiveness in systemic lupus erythematosus. Sci Transl Med. 2014;6:246ra299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3009131</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarola M, Comisso E, Pascolo R, Chiaradia R, Marion RM, Schneider C, et al. Epigenetic silencing of Oct4 by a complex containing SUV39H1 and Oct4 pseudogene lncRNA. Nat Commun. 2015;6:7631.</Citation><ArticleIdList><ArticleId IdType="pubmed">26158551</ArticleId><ArticleId IdType="doi">10.1038/ncomms8631</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Ji J, Lyu J, Jin X, He X, Mo S, et al. A novel urine exosomal lncRNA assay to improve the detection of prostate cancer at initial biopsy: a retrospective multicenter diagnostic feasibility study. Cancers (Basel). 2021;13:4075.</Citation><ArticleIdList><ArticleId IdType="pubmed">34439239</ArticleId><ArticleId IdType="pmc">8393262</ArticleId><ArticleId IdType="doi">10.3390/cancers13164075</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Zheng H, Luo Y, Kong Y, An M, Li Y, et al. Sumoylation promotes extracellular vesicle-mediated transmission of lncRNA ELNAT1 and lymph node metastasis in bladder cancer. J Clin Invest. 2021. https://doi.org/10.1172/JCI146431 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI146431</ArticleId><ArticleId IdType="pubmed">34907911</ArticleId><ArticleId IdType="pmc">8670847</ArticleId></ArticleIdList></Reference><Reference><Citation>Luan R, Tian G, Zhang H, Shi X, Li J, Zhang R, et al. Urinary exosomal circular RNAs of sex chromosome origin are associated with gender-related risk differences of clinicopathological features in patients with IgA nephropathy. J Nephrol. 2021;35:1069&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">34292531</ArticleId><ArticleId IdType="doi">10.1007/s40620-021-01118-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Abulaban KM, Fall N, Nunna R, Ying J, Devarajan P, Grom A, et al. Relationship of cell-free urine microRNA with lupus nephritis in children. Pediatr Rheumatol Online J. 2016;14:4.</Citation><ArticleIdList><ArticleId IdType="pubmed">26762103</ArticleId><ArticleId IdType="pmc">4712603</ArticleId><ArticleId IdType="doi">10.1186/s12969-016-0064-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Sol&#xe9; C, Molin&#xe9; T, Vidal M, Ordi-Ros J, Cort&#xe9;s-Hern&#xe1;ndez J. An exosomal urinary miRNA signature for early diagnosis of renal fibrosis in lupus nephritis. Cells. 2019;8:773.</Citation><ArticleIdList><ArticleId IdType="pubmed">31349698</ArticleId><ArticleId IdType="pmc">6721515</ArticleId><ArticleId IdType="doi">10.3390/cells8080773</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry CM, Balfour JA. Fomivirsen. Drugs. 1999;57:375&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">10193689</ArticleId><ArticleId IdType="doi">10.2165/00003495-199957030-00010</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Zhong L, Weng Y, Peng L, Huang Y, Zhao Y, et al. Therapeutic siRNA: state of the art. Signal Transduct Target Ther. 2020;5:101.</Citation><ArticleIdList><ArticleId IdType="pubmed">32561705</ArticleId><ArticleId IdType="pmc">7305320</ArticleId><ArticleId IdType="doi">10.1038/s41392-020-0207-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Kara G, Calin GA, Ozpolat B. RNAi-based therapeutics and tumor targeted delivery in cancer. Adv Drug Deliv Rev. 2022;182: 114113.</Citation><ArticleIdList><ArticleId IdType="pubmed">35063535</ArticleId><ArticleId IdType="doi">10.1016/j.addr.2022.114113</ArticleId></ArticleIdList></Reference><Reference><Citation>Kr&#xfc;tzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, et al. Silencing of microRNAs in vivo with &#x201c;antagomirs.&#x201d; Nature. 2005;438:685&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">16258535</ArticleId><ArticleId IdType="doi">10.1038/nature04303</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods. 2007;4:721&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">17694064</ArticleId><ArticleId IdType="doi">10.1038/nmeth1079</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortez MA, Ivan C, Valdecanas D, Wang X, Peltier HJ, Ye Y, et al. PDL1 regulation by p53 via miR-34. J Natl Cancer Inst. 2016. https://doi.org/10.1093/jnci/djv303 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/djv303</ArticleId><ArticleId IdType="pubmed">26577528</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong DS, Kang YK, Borad M, Sachdev J, Ejadi S, Lim HY, et al. Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. Br J Cancer. 2020;122:1630&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">32238921</ArticleId><ArticleId IdType="pmc">7251107</ArticleId><ArticleId IdType="doi">10.1038/s41416-020-0802-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Viltolarsen DS. First approval. Drugs. 2020;80:1027&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40265-020-01339-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott LJ, Lumasiran KSJ. First approval. Drugs. 2021;81:277&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">33405070</ArticleId><ArticleId IdType="doi">10.1007/s40265-020-01463-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkle M, El-Daly SM, Fabbri M, Calin GA. Noncoding RNA therapeutics - challenges and potential solutions. Nat Rev Drug Discov. 2021;20:629&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">34145432</ArticleId><ArticleId IdType="pmc">8212082</ArticleId><ArticleId IdType="doi">10.1038/s41573-021-00219-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Strasser DS, Froidevaux S, Sippel V, Gerossier E, Grieder U, Pierlot GM, et al. Preclinical to clinical translation of cenerimod, a novel S1P(1) receptor modulator, in systemic lupus erythematosus. RMD Open. 2020;6: e001261.</Citation><ArticleIdList><ArticleId IdType="pubmed">32917831</ArticleId><ArticleId IdType="pmc">7722385</ArticleId><ArticleId IdType="doi">10.1136/rmdopen-2020-001261</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlicher L, Kulig P, von M&#xfc;nchow A, Murphy MJ, Keller MP. In vitro characterization of sphingosine 1-phosphate receptor 1 (S1P(1)) expression and mediated migration of primary human t and b cells in the context of cenerimod, a novel, selective s1p(1) receptor modulator. Int J Mol Sci. 2022;23:1191.</Citation><ArticleIdList><ArticleId IdType="pubmed">35163112</ArticleId><ArticleId IdType="pmc">8835580</ArticleId><ArticleId IdType="doi">10.3390/ijms23031191</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiramatsu-Asano S, Sunahori-Watanabe K, Zeggar S, Katsuyama E, Mukai T, Morita Y, et al. Deletion of Mir223 exacerbates lupus nephritis by targeting S1pr1 in Fas(lpr/lpr) Mice. Front Immunol. 2020;11: 616141.</Citation><ArticleIdList><ArticleId IdType="pubmed">33574820</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2020.616141</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez-Gutierrez PR, Ceribelli A, Satoh M, Sobel ES, Reeves WH, Chan EK. Reduced levels of CCL2 and CXCL10 in systemic lupus erythematosus patients under treatment with prednisone, mycophenolate mofetil, or hydroxychloroquine, except in a high STAT1 subset. Arthritis Res Ther. 2014;16:R23.</Citation><ArticleIdList><ArticleId IdType="pubmed">24460726</ArticleId><ArticleId IdType="pmc">3978465</ArticleId><ArticleId IdType="doi">10.1186/ar4451</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecchi I, Perez-Sanchez C, Sciascia S, Radin M, Arias de la Rosa I, Barbarroja Puerto N, et al. Circulating microRNAs as potential biomarkers for monitoring the response to in vivo treatment with Rituximab in systemic lupus erythematosus patients. Autoimmun Rev. 2020;19:102488.</Citation><ArticleIdList><ArticleId IdType="pubmed">32062026</ArticleId><ArticleId IdType="doi">10.1016/j.autrev.2020.102488</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P, Guo Q, Qi Y, Hao Y, Gao Y, Zhi H, et al. LncACTdb 3.0: an updated database of experimentally supported ceRNA interactions and personalized networks contributing to precision medicine. Nucleic Acids Res. 2022;50:D183-d189.</Citation><ArticleIdList><ArticleId IdType="pubmed">34850125</ArticleId><ArticleId IdType="doi">10.1093/nar/gkab1092</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42:D92-97.</Citation><ArticleIdList><ArticleId IdType="pubmed">24297251</ArticleId><ArticleId IdType="doi">10.1093/nar/gkt1248</ArticleId></ArticleIdList></Reference><Reference><Citation>Sa&#xe7;arDemirci MD, Yousef M, Allmer J. Computational Prediction of Functional MicroRNA-mRNA Interactions. Methods Mol Biol. 2019;1912:175&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-8982-9_7</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie W, Flamant S, Rasko JE. Predicting microRNA targets and functions: traps for the unwary. Nat Methods. 2009;6:397&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">19478799</ArticleId><ArticleId IdType="doi">10.1038/nmeth0609-397</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell. 2003;115:787&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">14697198</ArticleId><ArticleId IdType="doi">10.1016/S0092-8674(03)01018-3</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>